Murine model of pneumococcal pneumonia
1Infection Immunology Research Group, Department of Microbial Pathogenesis, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Abstract:
Respiratory tract infections remain among the most common clinical problems worldwide. Pneumonia or inflammation of the lungs can be caused by infection with bacteria, viruses, and other organisms. Pneumonia management has been challenged by the widespread distribution of antibiotic-resistant strains of Streptococcus pneumoniae, the commonest cause of community acquired pneumonia. Experimental models of pneumonia have played a crucial role for testing the efficacy of antimicrobial agents as well as for gaining a better understanding of the disease pathogenesis. These models have also received increased attention as tools for deriving pharmacodynamic data and for determining the clinical significance of drug resistance.
Insights
Experimental pneumonia models are vital for understanding lung infection pathogenesis and testing new antimicrobial drugs, especially against resistant Streptococcus pneumoniae strains.
Area of Science:
- * Infectious Diseases
- * Microbiology
- * Pharmacology
Background:
- * Respiratory tract infections, including pneumonia, are a global health concern.
- * Community-acquired pneumonia is frequently caused by Streptococcus pneumoniae.
- * Antibiotic resistance in Streptococcus pneumoniae complicates pneumonia treatment.
Purpose of the Study:
- * To highlight the importance of experimental pneumonia models.
- * To emphasize their role in antimicrobial agent efficacy testing.
- * To underscore their utility in understanding disease pathogenesis and drug resistance.
Main Methods:
- * Review of existing literature on experimental pneumonia models.
- * Analysis of the role of these models in antimicrobial research.
- * Focus on their application in studying Streptococcus pneumoniae infections.
Main Results:
- * Experimental models are crucial for evaluating antimicrobial efficacy.
- * These models aid in deciphering pneumonia pathogenesis.
- * They are essential for assessing drug resistance impact.
Conclusions:
- * Experimental pneumonia models are indispensable tools in infectious disease research.
- * They facilitate the development of effective treatments against resistant pathogens.
- * Continued use of these models is vital for advancing pneumonia management.
